![Dennis D. Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis D. Kim
Chief Executive Officer at
Xeno Biosciences, Inc.
Profile
Dennis D.
Kim is President & Chief Executive Officer at Xeno Biosciences, Inc. Former positions include Executive Director-Strategy at Amylin Pharmaceuticals, Inc. from 2001 to 2007; Independent Director at Inversago Pharma, Inc. from 2019 to 2022; Chief Medical Officer at CymaBay Therapeutics, Inc. from 2021 to 2023; Senior VP-Medical Affairs & Communications at Orexigen Therapeutics, Inc. from 2010 to 2011; Chief Medical Officer at Zafgen, Inc. from 2011 to 2019; Chief Medical Officer at Cebix, Inc.; Assistant Professor at the University of California San Diego from 2001 to 2012; Chief Medical Officer & VP-Medical Affairs at EnteroMedics, Inc. from 2007 to 2008; Chief Medical Officer at Skye Bioscience, Inc. from 2019 to 2020; Chief Medical Officer at Emerald Health Sciences, Inc.; and Chief Medical Officer at AFYX Therapeutics AS.
Education includes a doctorate from Finch University of Health Sciences, an undergraduate degree from the University of California, Los Angeles, an MBA from Rady School of Management at UC San Diego, and a doctorate from Chicago Medical School.
Dennis D. Kim active positions
| Companies | Position | Start |
|---|---|---|
Xeno Biosciences, Inc.
 Xeno Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a novel class of treatments for metabolic diseases | Chief Executive Officer | - |
Former positions of Dennis D. Kim
| Companies | Position | End |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-02-19 |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Director/Board Member | 2022-10-18 |
| SKYE BIOSCIENCE, INC. | Chief Tech/Sci/R&D Officer | 2020-11-05 |
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-03-04 |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-12-31 |
Training of Dennis D. Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
Finch University of Health Sciences
 Finch University of Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EnteroMedics, Inc.
 EnteroMedics, Inc. Medical SpecialtiesHealth Technology Develops medical devices to treat obesity and gastrointestinal disorders | Health Technology |
Rady School of Management at UC San Diego
 Rady School of Management at UC San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Emerald Health Sciences, Inc.
 Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cannabinoid pharmaceutical drugs | Health Technology |
AFYX Therapeutics AS
 AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Xeno Biosciences, Inc.
Xeno Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a novel class of treatments for metabolic diseases | Health Technology |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Health Technology |
- Stock Market
- Insiders
- Dennis D. Kim
